Key Takeaway: Nurix Therapeutics is committed to developing innovative therapies by leveraging novel scientific insights. The company is advancing its multi-modal portfolio, which includes both wholly owned and partnered assets, aimed at addressing cancer and autoimmune diseases. Their resources focus on protein degradation, highlighting their dedication to high throughput purification methods.
Price reaction · baseline $15.17 (2024-05-24 close) · hit pre-market · 1 other NRIX headline(s) in the window, move may be shared
day 0 close · peak
+2.4%
Market Sentiment Analysis
POSITIVE FACTORS
Nurix is focused on translating scientific insights into therapies.
The company is advancing a multi-modal portfolio of assets.
Efforts are directed towards combating cancer and autoimmune diseases.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+85%
120-day peak, hindsight
Typical move
4.4%
average across 9 past catalysts
Cash runway
~14 mo
Low dilution risk
Lead asset
NX-5948
Phase 3 · B-cell Lymphoma
Full Press Release Details
RESOURCE LIBRARY
RESOURCE LIBRARY
At Nurix, we are dedicated to translating novel scientific insights into breakthrough therapies, advancing our multi-modal portfolio of wholly owned and partnered assets to outmatch cancer and autoimmune disease. Access our protein degradation resources below.
Filter by
Frequently Asked Questions
What is Nurix Therapeutics focused on?
Nurix Therapeutics is dedicated to translating scientific insights into breakthrough therapies.
What types of diseases does Nurix target?
The company targets cancer and autoimmune diseases with its therapies.
What resources does Nurix provide?
Nurix offers resources related to protein degradation and purification methods.